COVID-19: For information related to COVID-19 (formerly referred to as “novel coronavirus"), visit

VCU Massey Cancer Center


Top Facebook stories of 2015

What were you most interested in seeing on our Facebook page last year? Here's a round-up of the top 10 most popular FB posts of 2015. Comment to let us know your favorite one of the year, and if you'd like to see more posts in 2016 about any specific type of information, please let us know that too!

Massey scientists may have potentially discovered a way to make treatments for acute myeloid leukemia (AML) more effective! AML can be particularly difficult to cure, since patients often develop a resistance to standard therapies. However, a new, preclinical study suggests blocking a key protein could help overcome the drug resistance and potentially reduce the risk of relapse. Check out our news center to learn more!

"At Massey, with our multidisciplinary team, with our specialists, with our opportunity to give research as part of your treatment, we can offer you that global care that you need to survive breast cancer." Watch Dr. Mary Helen Hackney explain why Massey's expertise and collaborative approach make us your best choice for breast cancer care.

"Massey's Dr. Harry Bear, Dr. Mary Helen Hackney and Dr. Aimee Grover were recently honored at VCU School of Medicine's 17th Annual Faculty Excellence Awards! Congratulations to Dr. Bear who received the MCV Physicians Distinguished Clinician Award, Dr. Hackney who received the Leonard Tow Humanism in Medicine Award, and Dr. Grover who received the Women in Science, Dentistry, and Medicine Professional Achievement Award!" Visit our news center to read more.


Massey researchers have discovered in preclinical experiments that a common antibiotic synergizes with a drug called sabutoclax to destroy pancreatic cancer. This research was spearheaded by VCU M.D.-Ph.D. student Bridget Quinn, and is a promising new approach for a disease with very few treatment options. Follow the link to our blog to learn more!

Drs. Elisabeth Weiss and Geoff Hugo are leading three innovative clinical trials designed to improve tumor imaging during radiation treatment for lung cancer. Long a worldwide leader in the development of new radiation technologies, Massey is combining this expertise with discoveries in detection, prevention and treatment to make advancements against lung cancer.

We're excited to share that a new study led by Massey scientist Richard Moran, Ph.D., has uncovered a protein signaling process that could be responsible for the development of more than half of all cancers! Read our blog to learn about how mutations in the p53 gene lead to cancer growth, and the potential to develop new therapies that restore the gene's function.

Dr. Lenhardt has been a professor at Virginia Commonwealth University for almost 45 years and a patient at Massey since October. Unable to attend his daughter's wedding, we brought the wedding to him! Click to read this heartwarming story.

Great music and dancing. Check. Delicious food. Check. James River Cellars Winery. Check. Silent and live auction. Check. Fun. Of course! Don't miss out on attending Massey's summer tradition and grab your tickets for Massey Alliance's Moonlight Magic presented by Hunton & Williams LLP! We hope to see everyone from ‪Team Massey on June 6!

A new year, a new chance at life. Mackenzie was diagnosed with brain cancer just shy of her 2nd birthday. This year, she celebrates life as a 10 year old. Watch her incredible story and learn why this year is such a huge milestone for her and her family.

There's been lots of honking down here this morning! Congratulations!


Written by: Melissa Mitchell

Posted on: December 18, 2015

View graphic versionView graphic versionView graphic version